Issue Date | Title | Author(s) |
2012-06-04 | Deposition, diffusion and transport mechanism of dry powder microparticulate salbutamol, at the respiratory epithelia | Haghi, M; Traini, D; Bebawy, M; Young, PM |
2018-12-01 | Novel drug delivery approaches in treating pulmonary fibrosis | Dua, K; Awasthi, R; Madan, JR; Chellappan, DK; Nalluri, BN; Gupta, G; Bebawy, M; Hansbro, PM |
2015-06-01 | Anti-tumor activities of lipids and lipid analogues and their development as potential anticancer drugs | Murray, M; Hraiki, A; Bebawy, M; Pazderka, C; Rawling, T |
2013-05-01 | Salbutamol sulfate absorption across calu-3 bronchial epithelia cell monolayer is inhibited in the presence of common anionic NSAIDs | Mamlouk, M; Young, PM; Bebawy, M; Haghi, M; Mamlouk, S; Mulay, V; Traini, D |
2014-01-01 | Towards the bioequivalence of pressurised metered dose inhalers 2. Aerodynamically equivalent particles (with and without glycerol) exhibit different biopharmaceutical profiles in vitro | Haghi, M; Bebawy, M; Colombo, P; Forbes, B; Lewis, DA; Salama, R; Traini, D; Young, PM |
2014-01-01 | Proteome analysis of multidrug-resistant, breast cancer-derived microparticles | Pokharel, D; Padula, MP; Lu, JF; Tacchi, JL; Luk, F; Djordjevic, SP; Bebawy, M |
2013-06-01 | Ciprofloxacin is actively transported across bronchial lung epithelial cells using a calu-3 air interface cell model | Ong, HX; Traini, D; Bebawy, M; Young, PM |
2013-12-05 | Microparticle drug sequestration provides a parallel pathway in the acquisition of cancer drug resistance | Gong, J; Luk, F; Jaiswal, R; George, AM; Grau, GER; Bebawy, M |
2011-01 | Cellular release profiling of controlled release dry powder pulmonary formulation | Ong, HX; Traini, D; Bebawy, M; Young, P; Dalby, RN; Byron, PR; Peart, J; Suman, JD; Young, PM |
2018-04-01 | Immunological axis of curcumin-loaded vesicular drug delivery systems | Chellappan, DK; Ng, ZY; Wong, JY; Hsu, A; Wark, P; Hansbro, N; Taylor, J; Panneerselvam, J; Madheswaran, T; Gupta, G; Bebawy, M; Hansbro, PM; Dua, K |